Healio1d
GLP-1 may have potential to improve poststroke outcomes, prognosis
The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...
USA TODAY on MSN10d
Here's why researchers think most people stop taking weight loss drugs within a year
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
pharmaphorum8d
Novo Nordisk’s Victoza gets FDA okay for paediatric use
The FDA says the okay to use Victoza (liraglutide) in paediatric patients aged 10 or over comes “at a time when an increasing number of children are being diagnosed with this disease.” ...
The Terrible—and Amazing—Side Effects of Weight-Loss Drugs
PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a review in the Journal of Endocrinology. Credit not just the weight loss but ...